Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05306379 · ClinicalTrials.gov registry record · Phase 1
Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin
A Phase 1 study, sponsored by Aurinia Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT05306379 is a Phase 1 study that has completed, run by Aurinia Pharmaceuticals. The registered enrollment target is 24 participants.
The verdict
NCT05306379, a Phase 1 study, has completed, sponsored by Aurinia Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
A single-center, open-label, Phase 1, drug-drug interaction study to investigate the effect of voclosporin on the pharmacokinetics of simvastatin and simvastatin acid in healthy volunteers.
Interventions
- DRUG Simvastatin
- DRUG Voclosporin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-01-24 |
| Est. Completion | 2022-04-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05306379
The ClinicalTrials.gov registry entry for NCT05306379 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aurinia Pharmaceuticals, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Simvastatin is the first listed.
NCT05306379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05306379 about?
NCT05306379 is a clinical study titled "Drug-Drug Interaction Study to Investigate Effects of Voclosporin on Pharmacokinetics of Simvastatin". A single-center, open-label, Phase 1, drug-drug interaction study to investigate the effect of voclosporin on the pharmacokinetics of simvastatin and simvastatin acid in healthy volunteers.
What is the current status of trial NCT05306379?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2022-01-24. Estimated completion is 2022-04-05.
What interventions are being tested in trial NCT05306379?
The interventions under investigation include: Simvastatin (DRUG), Voclosporin (DRUG).
Who is sponsoring clinical trial NCT05306379?
This trial is sponsored by Aurinia Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.